CORIXA CORPORATION
250Patents
46Active
250Granted
43Portfolio score
Filing activity: Jul 28, 1994 → Sep 13, 2019 · 40 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6303347A | Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors | Chemistry; Metallurgy | 97 | Expired |
| US6261562A | Compounds for immunotherapy of prostate cancer and methods for their use | Chemistry; Metallurgy | 71 | Expired |
| US6649172B2 | Amphipathic aldehydes and their uses as adjuvants and immunoeffectors | Chemistry; Metallurgy | 68 | Expired |
| US6525028B1 | Immunoeffector compounds | Chemistry; Metallurgy | 66 | Expired |
| US6444425B1 | Compounds for therapy and diagnosis of lung cancer and methods for their use | Human Necessities | 62 | Expired |
| US7749505B2 | Compositions and methods for the therapy and diagnosis of lung cancer | Chemistry; Metallurgy | 59 | Active |
| US7258860B2 | Compositions and methods for the therapy and diagnosis of lung cancer | Chemistry; Metallurgy | 59 | Expired |
| US7579160B2 | Methods for the detection of cervical cancer | Chemistry; Metallurgy | 58 | Expired |
| US7585506B2 | Compositions and methods for the therapy and diagnosis of lung cancer | Chemistry; Metallurgy | 58 | Active |
| US6355257B1 | Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors | Human Necessities | 57 | Expired |
| US6262245A | Compounds for immunotherapy of prostate cancer and methods for their use | Chemistry; Metallurgy | 54 | Expired |
| US6555653B2 | Compounds for diagnosis of tuberculosis and methods for their use | Chemistry; Metallurgy | 52 | Expired |
| US6491919B2 | Aqueous immunologic adjuvant compostions of monophosphoryl lipid A | Human Necessities | 51 | Expired |
| US6034218A | Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer | Human Necessities | 49 | Expired |
| US6231869A | Compounds and methods for the diagnosis and treatment of ehrlichia infection | Emerging Cross-Sectional Technologies | 47 | Expired |
| US5986170A | Murine model for human carcinoma | Human Necessities | 46 | Expired |
| US6207169A | Compounds and methods for the diagnosis and treatment of Ehrlichia infection | Emerging Cross-Sectional Technologies | 45 | Expired |
| US8920776B2 | Compositions and methods for the detection diagnosis and therapy of hematological malignancies | Chemistry; Metallurgy | 45 | Active |
| US7087713B2 | Compounds and methods for diagnosis and immunotherapy of tuberculosis | Physics | 44 | Expired |
| US7037509B2 | Immunologically significant herpes simplex virus antigens and methods for using same | Chemistry; Metallurgy | 40 | Expired |
| US7063854B1 | Composition and methods for WTI specific immunotherapy | Human Necessities | 40 | Expired |
| US7261897B2 | Fusion proteins of mycobacterium tuberculosis | Chemistry; Metallurgy | 40 | Expired |
| US5876735A | Methods for enhancement of protective immune responses | Emerging Cross-Sectional Technologies | 40 | Expired |
| US6800746B2 | Compositions and methods for the therapy and diagnosis of prostate cancer | Chemistry; Metallurgy | 39 | Expired |
| US6306402A | Compounds and methods for the diagnosis and treatment of EHRLICHIA infection | Emerging Cross-Sectional Technologies | 39 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.